New clinical endpoints and digitally measured endpoints

The use of digital tools to measure primary and secondary endpoints is still exploratory and not established as a gold standard.

What digital measures are already in use in clinical research? Who are the early adopter sponsors investing in these technologies? How to ensure the digital endpoints collected with digital health solutions meet the requirements of regulatory authorities and other stakeholders? What are the therapeutic areas that might benefit the most from including digital endpoints in clinical trials? Are there any best practices when identifying and selecting digital endpoints? We want to hear from those trialling digital endpoints and those supporting its validation, adoption.